Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comfrey Presents "Serious Health Hazard," ONPLDS Tells Industry

This article was originally published in The Tan Sheet

Executive Summary

Marketers of comfrey-containing dietary supplements should recall all such products or face direct enforcement action, FDA asserts in a July 6 letter sent to eight trade groups.
Advertisement

Related Content

Christopher Enterprises Comfrey Marketing For Internal Use Barred
Christopher Enterprises Comfrey Marketing For Internal Use Barred
Christopher Enterprises Comfrey Marketing For Internal Use Barred
Comfrey
Comfrey
Comfrey
Comfrey
Streamline International Comfrey Supplements Not GRAS - FTC Lawsuit
Streamline International Comfrey Supplements Not GRAS - FTC Lawsuit
HIV/AIDS, Cancer Cure Supplement Claims Targeted In Six FTC Actions

Topics

Advertisement
UsernamePublicRestriction

Register

PS092756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel